Claus Elsborg Olesen
Fondatore presso INITIATOR PHARMA A/S
Posizioni attive di Claus Elsborg Olesen
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| INITIATOR PHARMA A/S | Direttore/Membro del Consiglio | 01/01/2016 | - |
| Amministratore Delegato | 01/01/2016 | - | |
| Fondatore | 01/01/2016 | - | |
STipe Therapeutics ApS
 STipe Therapeutics ApS Pharmaceuticals: MajorHealth Technology STipe Therapeutics ApS operates as a biotechnology company. It specializes in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer. The company was founded in 2018 and is headquartered in Denmark. | Amministratore Delegato | 01/01/2018 | - |
| Fondatore | 01/01/2018 | - |
Storia della carriera di Claus Elsborg Olesen
Precedenti posizioni note di Claus Elsborg Olesen
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
NMD Pharma A/S
 NMD Pharma A/S BiotechnologyHealth Technology NMD Pharma ApS engages with the research and preparation of small molecules targeting an undisclosed ion. It offers medical treatment of neuromuscular diseases for patients with chronic muscle wasting diseases such as myasthenia gravis and amyotrophic lateral sclerosis. The company was founded by Ole B?kgaard Nielsen, Thomas Holm Pedersen, and Claus Elsborg Olesen on May 7, 2015 and is headquartered in Aarhus, Denmark. | Direttore/Membro del Consiglio | 07/05/2015 | - |
| Fondatore | 07/05/2015 | - | |
Pcovery ApS
 Pcovery ApS Pharmaceuticals: MajorHealth Technology Pcovery ApS develops drugs for treatment of invasive fungal infections. It discovers a new class of fungal therapy by targeting an essential and highly conserved component of the fungal cell membrane. The company was founded by Morten J. Buch-Pedersen, Michael Broberg Palmgren, Claus Olesen and Poul Nissen in 2009 and is headquartered in Copenhagen, Denmark. | Fondatore | 01/01/2009 | - |
Formazione di Claus Elsborg Olesen
| University of Aarhus | Doctorate Degree |
Statistiche
Distribuzione geografica
| Danimarca | 6 |
Posizioni
| Founder | 4 |
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
Settori
| Health Technology | 5 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| INITIATOR PHARMA A/S | Health Technology |
| Aziende private | 3 |
|---|---|
Pcovery ApS
Pcovery ApS Pharmaceuticals: MajorHealth Technology Pcovery ApS develops drugs for treatment of invasive fungal infections. It discovers a new class of fungal therapy by targeting an essential and highly conserved component of the fungal cell membrane. The company was founded by Morten J. Buch-Pedersen, Michael Broberg Palmgren, Claus Olesen and Poul Nissen in 2009 and is headquartered in Copenhagen, Denmark. | Health Technology |
NMD Pharma A/S
NMD Pharma A/S BiotechnologyHealth Technology NMD Pharma ApS engages with the research and preparation of small molecules targeting an undisclosed ion. It offers medical treatment of neuromuscular diseases for patients with chronic muscle wasting diseases such as myasthenia gravis and amyotrophic lateral sclerosis. The company was founded by Ole B?kgaard Nielsen, Thomas Holm Pedersen, and Claus Elsborg Olesen on May 7, 2015 and is headquartered in Aarhus, Denmark. | Health Technology |
STipe Therapeutics ApS
STipe Therapeutics ApS Pharmaceuticals: MajorHealth Technology STipe Therapeutics ApS operates as a biotechnology company. It specializes in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer. The company was founded in 2018 and is headquartered in Denmark. | Health Technology |
- Borsa valori
- Insiders
- Claus Elsborg Olesen
- Esperienza